TickerFacts.

Company research / MMED

MiniMed Group, Inc. (MMED)

Also trades as MMEDV. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0002062583 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2026-04-24, MiniMed Group, Inc. reported revenue of $3.10B. Revenue grew 14.3% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $3.22B.

Key ratios (year ended 2026-04-24)

54.2%
Gross margin
-6.1%
Operating margin
-10.7%
Net margin
-9.2%
Return on year-end equity
14.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31		2026-04-242025-04-252024-04-26
Revenue$3.22B$3.10B$2.71B$2.47B
Cost of Revenue$1.49B$1.42B$1.19B$1.03B
Gross Profit$1.74B$1.68B$1.53B$1.44B
R&D Expense$438.00M$448.00M$436.00M$437.00M
Operating Income-$172.00M-$190.00M-$146.00M-$69.00M
Depreciation & Amortization$158.00M$156.00M$143.00M$129.00M
EBITDA-$14.00M-$34.00M-$3.00M$60.00M
Net Income-$314.00M-$333.00M-$213.00M-$112.00M
EPS (Diluted)n/a-$1.30-$0.84-$0.44
Total Assets$4.72B$4.63B$4.20Bn/a
Total Liabilities$1.10B$1.02B$871.00Mn/a
Shareholders' Equity$3.62B$3.61B$3.33B$3.45B
Cash & Equivalents$207.00M$298.00M$11.00Mn/a
Operating Cash Flow-$105.00M-$197.00M$140.00M$41.00M
Capital Expenditures$211.00M$223.00M$193.00M$148.00M
Free Cash Flow-$316.00M-$420.00M-$53.00M-$107.00M
Shares Outstanding281.21M280.82Mn/an/a
Weighted Average Diluted Sharesn/a256.60M252.80M252.80M
EPS (Basic)n/a-$1.30-$0.84-$0.44

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView